Effect of amyloid‐β (A β) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK )‐3β
Volume: 41, Issue: 4, Pages: 445 - 457
Published: May 13, 2015
Abstract
Aims Active amyloid‐β ( A β) immunotherapy in Alzheimer's disease ( AD ) induces removal of Aβ and phosphorylated tau (ptau). Glycogen synthase kinase ( GSK )‐3β is a kinase, responsible for phosphorylation of tau, activation of which can be induced by phosphorylated double‐stranded RNA ‐dependent protein kinase (p PKR ). Using a post‐mortem cohort of immunized AD cases, we investigated the effect of A β immunization on GSK ‐3β expression and p...
Paper Details
Title
Effect of amyloid‐β (A β) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK )‐3β
Published Date
May 13, 2015
Volume
41
Issue
4
Pages
445 - 457
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History